If the final level on the valuation date is greater than the initial level of 2,547.25 (which was the closing level of the referenceasset on the trade date), the return on your notes will be positive and will equal the participation rate of 150.00% times thereference asset return, which is the percentage increase or decrease in the final level from the initial level, subject to themaximum payment amount of $1,271.80 for each $1,000 principal amount of your notes. If the final level declines by up to10.00% from the initial level, you will receive the principal amount of your notes.If the final level declines by more than10.00% from the initial level, the return on your notes will be negative and you may lose up to your entire principal To determine your payment at maturity, we will first calculate the reference asset return. At maturity, for each $1,000principal amount of your notes: ●if the final level isgreater thanthe initial level (the reference asset return is positive), you will receive an amount incash equal to thesumof (i) $1,000plus(ii) theproductof (a) $1,000times(b) the reference asset returntimes(c) the participation rate, subject to the maximum payment amount;●if the final level isequal tothe initial level orless thanthe initial level, but not by more than 10.00% (the reference assetreturn iszero or negative butequal toorgreater than-10.00%), you will receive an amount in cash equal to $1,000;or●if the final level isless thanthe initial level by more than 10.00% (the reference asset return is negative and isless than Following the determination of the initial level, the amount you will be paid on your notes at maturity will not be affected bythe closing level of the reference asset on any day other than the valuation date.In addition, no payments on your noteswill be made prior to maturity. Investment in the notes involves certain risks. You should refer to “Additional Risks” beginning on page P-15 ofthis pricing supplement and “Additional Risk Factors Specific to the Notes” beginning on page PS-6 of theaccompanying product supplement and “Risk Factors” beginning on page S-2 of the accompanying prospectus The initial estimated value of your notes at the time the terms of your notes were set on the trade date was $983.10per $1,000 principal amount, which is less than the original issue price of your notes listed below.See “AdditionalInformation Regarding Estimated Value of the Notes” on the following page and “Additional Risks” beginning on page P-15 1For additional information, see “Supplemental Plan of Distribution (Conflicts of Interest)” herein. Neither the United States Securities and Exchange Commission (the “SEC”) nor any state securities commissionhasapproved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricingsupplement, the accompanying prospectus, prospectus supplement, underlier supplement or product supplement. The notes are not insured by the Canada Deposit Insurance Corporation (the “CDIC”) pursuant to the CanadaDeposit Insurance Corporation Act (the “CDIC Act”) or the U.S. Federal Deposit Insurance Corporation or any othergovernment agency of Canada, the United States or any other jurisdiction. Scotia Capital (USA) Inc.Sachs & Co. LLCDealer Goldman Pricing Supplement dated May 15, 2025 The Capped Buffered Enhanced Participation Notes Linked to theMSCI EAFE®Index Due May 19, 2027 (the “notes”) offeredhereunder are unsubordinated and unsecured obligations of The Bank of Nova Scotia (the “Bank”) and are subject to investmentrisks including possible loss of the principal amount invested due to the negative performance of the reference asset and thecredit risk of the Bank. As used in this pricing supplement, the “Bank,” “we,” “us” or “our” refers to The Bank of Nova Scotia. The The return on your notes will relate to the price return of the reference asset and will not include a total return or dividendcomponent. The notes are derivative products based on the performance of the reference asset. The notes do not constitute adirect investment in any of the shares, units or other securities represented by the reference asset. By acquiring the notes, you willnot have a direct economic or other interest in, claim or entitlement to, or any legal or beneficial ownership of any such share, unit Scotia Capital (USA) Inc. (“SCUSA”), our affiliate, has agreed to purchase the notes from us for distribution to other registeredbroker dealers. SCUSA or any of its affiliates or agents may use this pricing supplement in market-making transactions in notesafter their initial sale. Unless we, SCUSA or another of our affiliates or agents selling such notes to you informs you otherwise inthe confirmation of sale, this pricing supplement is being used in a market-making transaction. See “Supplemental Plan ofDistribution (Conflicts of Interest)” in this pricing supplement and “Supplemental Plan of Distribution (Conflicts of Interest)” in the The original iss